Meta-analysis Comparing Outcomes in Patients With and Without Cardiac Injury and Coronavirus Disease 2019 (COVID 19)
- PMID: 33217345
- PMCID: PMC7671934
- DOI: 10.1016/j.amjcard.2020.11.009
Meta-analysis Comparing Outcomes in Patients With and Without Cardiac Injury and Coronavirus Disease 2019 (COVID 19)
Abstract
Current evidence is limited to small studies describing the association between cardiac injury and outcomes in patients with coronavirus disease 2019 (COVID-19). To address this, we performed a comprehensive meta-analysis of studies in COVID-19 patients to evaluate the association between cardiac injury and all-cause mortality, intensive care unit (ICU) admission, mechanical ventilation, acute respiratory distress syndrome, acute kidney injury and coagulopathy. Further, studies comparing cardiac biomarker levels in survivors versus nonsurvivors were included. A total of 14 studies (3,175 patients) were utilized for the final analysis. Cardiac injury in patients with COVID-19 was associated with higher risk of mortality (risk ratio [RR]:7.79; 95% confidence interval [CI]: 4.69 to 13.01; I2=58%), ICU admission (RR: 4.06; 95% CI: 1.50 to 10.97; I2 = 61%), mechanical ventilation (RR: 5.53; 95% CI: 3.09 to 9.91; I2 = 0%), and developing coagulopathy (RR: 3.86; 95% CI:2.81 to 5.32; I2 = 0%). However, cardiac injury was not associated with increased risk of acute respiratory distress syndrome (RR:3.22; 95% CI:0.72 to 14.47; I2 = 73%) or acute kidney injury (RR: 11.52, 95% CI:0.03 to 4,159.80; I2 = 0%). The levels of hs-cTnI (MD:34.54 pg/ml;95% CI: 24.67 to 44.40 pg/ml; I2 = 88%), myoglobin (MD:186.81 ng/ml; 95% CI: 121.52 to 252.10 ng/ml; I2 = 88%), NT-pro BNP (MD:1183.55 pg/ml; 95% CI: 520.19 to 1846.91 pg/ml: I2 = 96%) and CK-MB (MD:2.49 ng/ml;95% CI: 1.86 to 3.12 ng/ml; I2 = 90%) were significantly elevated in nonsurvivors compared with survivors with COVID-19 infection. The results of this meta-analysis suggest that cardiac injury is associated with higher mortality, ICU admission, mechanical ventilation and coagulopathy in patients with COVID-19.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosures The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures





Similar articles
-
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China.JAMA Cardiol. 2020 Jul 1;5(7):802-810. doi: 10.1001/jamacardio.2020.0950. JAMA Cardiol. 2020. PMID: 32211816 Free PMC article.
-
Cardiac injury associated with severe disease or ICU admission and death in hospitalized patients with COVID-19: a meta-analysis and systematic review.Crit Care. 2020 Jul 28;24(1):468. doi: 10.1186/s13054-020-03183-z. Crit Care. 2020. PMID: 32723362 Free PMC article.
-
Risk factors for the exacerbation of patients with 2019 Novel Coronavirus: A meta-analysis.Int J Med Sci. 2020 Jul 6;17(12):1744-1750. doi: 10.7150/ijms.47052. eCollection 2020. Int J Med Sci. 2020. PMID: 32714077 Free PMC article.
-
Liver disease and outcomes among COVID-19 hospitalized patients - A systematic review and meta-analysis.Ann Hepatol. 2021 Mar-Apr;21:100273. doi: 10.1016/j.aohep.2020.10.001. Epub 2020 Oct 16. Ann Hepatol. 2021. PMID: 33075578 Free PMC article.
-
The impact of 2019 novel coronavirus on heart injury: A Systematic review and Meta-analysis.Prog Cardiovasc Dis. 2020 Jul-Aug;63(4):518-524. doi: 10.1016/j.pcad.2020.04.008. Epub 2020 Apr 16. Prog Cardiovasc Dis. 2020. PMID: 32305557 Free PMC article.
Cited by
-
Cardiac Injury in COVID-19: A Systematic Review of Relevant Meta-Analyses.Rev Cardiovasc Med. 2022 Dec 12;23(12):404. doi: 10.31083/j.rcm2312404. eCollection 2022 Dec. Rev Cardiovasc Med. 2022. PMID: 39076653 Free PMC article.
-
Serum Neurofilament Light is elevated in COVID-19 Positive Adults in the ICU and is associated with Co-Morbid Cardiovascular Disease, Neurological Complications, and Acuity of Illness.Cardiol Cardiovasc Med. 2021 Oct;5(5):551-565. doi: 10.26502/fccm.92920221. Epub 2021 Oct 13. Cardiol Cardiovasc Med. 2021. PMID: 34708189 Free PMC article.
-
The impact of COVID-19 on hospitalization outcomes of patients with acute myocardial infarction in the USA.Am Heart J Plus. 2023 Aug;32:100305. doi: 10.1016/j.ahjo.2023.100305. Epub 2023 Jun 12. Am Heart J Plus. 2023. PMID: 37337595 Free PMC article.
-
The Role of Multidisciplinary Approaches in the Treatment of Patients with Heart Failure and Coagulopathy of COVID-19.J Cardiovasc Dev Dis. 2023 Jun 3;10(6):245. doi: 10.3390/jcdd10060245. J Cardiovasc Dev Dis. 2023. PMID: 37367410 Free PMC article. Review.
-
COVID-19 and myocardial injury: Targeting elevated biomarkers for potential novel therapies.Clinics (Sao Paulo). 2024 Aug 27;79:100473. doi: 10.1016/j.clinsp.2024.100473. eCollection 2024. Clinics (Sao Paulo). 2024. PMID: 39197405 Free PMC article.
References
-
- Anon. Coronavirus Disease (COVID-19) Situation Reports. Available at:https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situatio.... Accessed September 26, 2020.
-
- Anon. COVID-19 Map - Johns Hopkins Coronavirus Resource Center. Available at: https://coronavirus.jhu.edu/map.html. Accessed September 26, 2020.
-
- Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323:1061–1069. doi: 10.1001/jama.2020.1585. - DOI - PMC - PubMed
-
- Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, Gong W, Liu X, Liang J, Zhao Q, Huang H, Yang B, Huang C. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802–810. http://www.embase.com/search/results?subaction=viewrecord&from=export&id... Available at: Accessed September 26, 2020. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous